Familial apolipoprotein C-II deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309020OMIM:207750E78.3
Who is this for?
Show terms as
1Active trials1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial apolipoprotein C-II (apo C-II) deficiency is a very rare inherited disorder of fat metabolism. It is also known as familial chylomicronemia due to apo C-II deficiency or hyperlipoproteinemia type Ib. In this condition, the body cannot properly break down certain fats (triglycerides) in the blood because it lacks a key protein called apolipoprotein C-II. This protein normally activates an enzyme called lipoprotein lipase, which is responsible for clearing fat particles (chylomicrons and very low-density lipoproteins) from the bloodstream. Without functioning apo C-II, triglyceride levels become extremely high, often reaching thousands of milligrams per deciliter. The hallmark symptom is recurrent episodes of acute pancreatitis, which causes severe abdominal pain and can be life-threatening. Other common signs include eruptive xanthomas (small yellowish bumps on the skin caused by fat deposits), lipemia retinalis (a milky appearance of the blood vessels in the eye), and hepatosplenomegaly (enlarged liver and spleen). The blood itself may appear milky or creamy due to the extremely high fat content. Treatment centers on a very strict low-fat diet, typically limiting dietary fat to 10-20 grams per day. There are currently no widely approved drug therapies that specifically correct the underlying protein deficiency, though newer gene therapies and antisense treatments for related conditions are being studied. Managing and preventing pancreatitis episodes is the primary goal of care. With careful dietary management, many patients can reduce the frequency of dangerous complications.

Also known as:

Key symptoms:

Severe abdominal pain from pancreatitisExtremely high triglyceride levels in the bloodMilky or creamy-looking bloodSmall yellowish bumps on the skin (eruptive xanthomas)Enlarged liverEnlarged spleenMilky appearance of blood vessels in the back of the eyeNausea and vomitingLoss of appetiteFatty deposits around tendons or jointsAbdominal bloating or discomfortFatigue

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Dec 2021Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

Arrowhead Pharmaceuticals — PHASE3

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Familial apolipoprotein C-II deficiency.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 31 trial
Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)
Phase 3
Active
· Sites: Boca Raton, Florida; Suwanee, Georgia +56 more · Age: 1899 yrs

Specialists

1 foundView all specialists →
RM
Robert D Fishberg, MD
SPRINGFIELD, NJ
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial apolipoprotein C-II deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial apolipoprotein C-II deficiencyForum →

No community posts yet. Be the first to share your experience with Familial apolipoprotein C-II deficiency.

Start the conversation →

Latest news about Familial apolipoprotein C-II deficiency

No recent news articles for Familial apolipoprotein C-II deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How low should my daily fat intake be, and can a dietitian help me plan meals?,What are the warning signs of pancreatitis, and when should I go to the emergency room?,Should my family members be tested for this condition or carrier status?,Are there any newer treatments or clinical trials I should know about?,How often should I have my triglyceride levels checked?,Do I need to take vitamin supplements because of my restricted diet?,What should I do if I accidentally eat a high-fat meal — is there an emergency plan?

Common questions about Familial apolipoprotein C-II deficiency

What is Familial apolipoprotein C-II deficiency?

Familial apolipoprotein C-II (apo C-II) deficiency is a very rare inherited disorder of fat metabolism. It is also known as familial chylomicronemia due to apo C-II deficiency or hyperlipoproteinemia type Ib. In this condition, the body cannot properly break down certain fats (triglycerides) in the blood because it lacks a key protein called apolipoprotein C-II. This protein normally activates an enzyme called lipoprotein lipase, which is responsible for clearing fat particles (chylomicrons and very low-density lipoproteins) from the bloodstream. Without functioning apo C-II, triglyceride leve

How is Familial apolipoprotein C-II deficiency inherited?

Familial apolipoprotein C-II deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Familial apolipoprotein C-II deficiency?

Yes — 1 recruiting clinical trial is currently listed for Familial apolipoprotein C-II deficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Familial apolipoprotein C-II deficiency?

1 specialists and care centers treating Familial apolipoprotein C-II deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.